Fortitude Family Office’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$432 Sell
82
-12
-13% -$71 ﹤0.01% 2431
2026
Q2
$606 Buy
+94
New +$622 ﹤0.01% 1932
2026
Q1
– Sell
-271
Closed -$1.82K – 1983
2025
Q4
$1.82K Sell
271
-147
-35% -$1.1K ﹤0.01% 1217
2025
Q3
$3.42K Buy
418
+147
+54% +$1.1K ﹤0.01% 970
2025
Q2
$1.91K Buy
+271
New +$1.82K ﹤0.01% 1221

Other funds holding INGN

Fortitude Family Office's INGN Position: Q3 2026 in Review

Fortitude Family Office reduced its Inogen (INGN) stake by 13% in Q3 2026, selling an estimated $71 and leaving 82 shares worth $432. The position accounts for ﹤0.01% of the portfolio, ranked #2431.

Fortitude Family Office first reported a position in INGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.42K in Q3 2025. 7 funds tracked by Wall St. Rank hold INGN as of Q3 2026.

  • Fortitude Family Office held 82 shares of Inogen worth $432 as of Q3 2026.
  • Fortitude Family Office sold 12 Inogen shares in Q3 2026, an estimated $71.
  • Inogen made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2431 holding.
  • Fortitude Family Office first reported a position in Inogen in Q2 2025 and has held it in 5 quarters since.
  • Fortitude Family Office's Inogen position peaked at $3.42K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Inogen as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.